CANNONAU CORP - CNNC STOCK NEWS

Cannonau Corp (OTC PINK:CNNC) announced the appointment of Dr. Douglas Pitchford as medical advisor, leveraging his expertise in CBD for pain management. With over 36 years of experience, Dr. Pitchford will evaluate and communicate medical information regarding Cannonau's products. His role includes supporting clinical research and training sales personnel, aiming to enhance company growth and strategic decision-making. Cannonau's CEO, Carmen Carbona, highlighted Dr. Pitchford's significance in promoting efficiencies and benefiting stakeholders. The company focuses on high-quality, full-spectrum CBD products.

Cannonau Corp (OTC PINK:CNNC) has appointed Mr. Fruqan Mouzon as an Advisor specializing in Cannabis Law. Mr. Mouzon has vast experience, including roles in New Jersey government and private legal practice. His focus will be on assisting clients in establishing cannabis businesses while fostering opportunities for minorities and women in the industry. The CEO, Carmen Carbona, expressed confidence that Mr. Mouzon's expertise will be crucial for the company's growth, guiding strategic decisions, and enhancing client relationships.

Virtual Medical International Inc. (OTC: QEBR) announced a distribution agreement with Cannonau Corp (OTC: CNNC) effective April 30, 2021. This agreement allows QEBR to distribute Cannonau's Full-Spectrum CBD products globally through various sales channels, enhancing QEBR's presence in the CBD market. CEO Larson Elmore emphasized that this partnership marks a significant step in expanding their business. Cannonau's CEO, Carmen Carbona, expressed confidence in QEBR's capabilities to leverage their products effectively. Additional announcements are anticipated to follow.

Cannonau Corp (OTC:CNNC) has announced a distribution agreement with Virtual Medical International, Inc. (OTC:QEBR) effective April 30, 2021. This partnership enables Virtual Medical to distribute Cannonau's Full-Spectrum CBD products online and in retail outlets globally. Cannonau aims to strengthen its market presence through this collaboration, leveraging Virtual Medical's diverse retail channels and commitment to quality. CEO Carmen Carbona expressed confidence in the partnership's potential to enhance sales and market reach.

Cannonau Corporation (OTC PINK:CNNC) is offering a buy one get one free promotion on its Full-Spectrum CBD products through April 30, 2021. This initiative aims to assist individuals coping with the challenges of extended quarantines by promoting relaxation and wellness. Cannonau emphasizes the benefits of CBD in maintaining balance within the body’s endocannabinoid system, which influences mood, immune response, and metabolism. The promotion reflects the company's commitment to enhancing physical and psychological well-being during uncertain times.

Cannonau Corp. (OTC PINK:CNNC) has submitted its application for uplisting to the OTCQB market, a step aimed at boosting transparency and compliance. The OTCQB requires companies to meet rigorous standards, enhancing reporting and providing current information to investors. CEO Carmen Carbona believes this move will significantly increase visibility and attract a broader shareholder base. Cannonau Corp. specializes in Full-Spectrum Hemp-CBD products, focusing on quality and consumer education. The company is committed to maintaining high standards and transparency in the CBD market.

Cannonau Corp (OTC PINK:CNNC) has launched its new website focused on premium, full-spectrum CBD products. The site features an array of offerings, including CBD relief rubs, oral sprays, tinctures, and a dedicated pet care line. All products are derived from high-quality, non-GMO, organically grown US industrial hemp. CEO Carmen Carbona emphasized the company’s commitment to providing natural, effective solutions for enhancing health and wellness. The launch aims to educate consumers on the benefits of CBD while promoting transparency and purity in their products.